TY - JOUR
T1 - Genotype-phenotype spectrum of PYCR1-related autosomal recessive cutis laxa
AU - Dimopoulou, Aikaterini
AU - Fischer, Björn
AU - Gardeitchik, Thatjana
AU - Schröter, Phillipe
AU - Kayserili, Hülya
AU - Schlack, Claire
AU - Li, Yun
AU - Brum, Jaime Moritz
AU - Barisic, Ingeborg
AU - Castori, Marco
AU - Spaich, Christiane
AU - Fletcher, Elaine
AU - Mahayri, Zeina
AU - Bhat, Meenakshi
AU - Girisha, Katta M.
AU - Lachlan, Katherine
AU - Johnson, Diana
AU - Phadke, Shubha
AU - Gupta, Neerja
AU - Simandlova, Martina
AU - Kabra, Madhulika
AU - David, Albert
AU - Nijtmans, Leo
AU - Chitayat, David
AU - Tuysuz, Beyhan
AU - Brancati, Francesco
AU - Mundlos, Stefan
AU - Van Maldergem, Lionel
AU - Morava, Eva
AU - Wollnik, Bernd
AU - Kornak, Uwe
PY - 2013/11
Y1 - 2013/11
N2 - Autosomal recessive cutis laxa type 2B (ARCL2B; OMIM # 612940) is a segmental progeroid disorder caused by mutations in PYCR1 encoding pyrroline-5-carboxylate reductase 1, which is part of the conserved proline de novo synthesis pathway. Here we describe 33 patients with PYCR1-related ARCL from 27 families with initial diagnoses varying between wrinkly skin syndrome, gerodermia osteodysplastica, De Barsy syndrome or more severe progeria syndromes. Given the difficult differential diagnosis of ARCL syndromes we performed a systematic comparison of clinical features of PYCR1-related ARCL. Intrauterine growth retardation, a characteristic triangular facial gestalt, psychomotor retardation, and hypotonia were the most relevant distinctive hallmarks of ARCL due to proline de novo synthesis defects. Corneal clouding or cataracts, athetoid movements, and finger contractures were rather rare features, but had a high predictive value. In our cohort we identified 20 different PYCR1 mutations of which seven were novel. Most of the mutations accumulated in exons 4 to 6. Missense alterations of highly conserved residues were most frequent followed by splice site changes and a single nonsense mutation. Analysis of genotype-phenotype correlation revealed that patients with mutations in the first two exons had lower average clinical scores and absent or only mild intellectual disability. Structural analyses predicted interference with PYCR1 multimerization for a subset of missense mutations. These findings have implications for the clinics as well as the pathomechanism of PYCR1-related ARCL.
AB - Autosomal recessive cutis laxa type 2B (ARCL2B; OMIM # 612940) is a segmental progeroid disorder caused by mutations in PYCR1 encoding pyrroline-5-carboxylate reductase 1, which is part of the conserved proline de novo synthesis pathway. Here we describe 33 patients with PYCR1-related ARCL from 27 families with initial diagnoses varying between wrinkly skin syndrome, gerodermia osteodysplastica, De Barsy syndrome or more severe progeria syndromes. Given the difficult differential diagnosis of ARCL syndromes we performed a systematic comparison of clinical features of PYCR1-related ARCL. Intrauterine growth retardation, a characteristic triangular facial gestalt, psychomotor retardation, and hypotonia were the most relevant distinctive hallmarks of ARCL due to proline de novo synthesis defects. Corneal clouding or cataracts, athetoid movements, and finger contractures were rather rare features, but had a high predictive value. In our cohort we identified 20 different PYCR1 mutations of which seven were novel. Most of the mutations accumulated in exons 4 to 6. Missense alterations of highly conserved residues were most frequent followed by splice site changes and a single nonsense mutation. Analysis of genotype-phenotype correlation revealed that patients with mutations in the first two exons had lower average clinical scores and absent or only mild intellectual disability. Structural analyses predicted interference with PYCR1 multimerization for a subset of missense mutations. These findings have implications for the clinics as well as the pathomechanism of PYCR1-related ARCL.
UR - http://www.scopus.com/inward/record.url?scp=84885427893&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885427893&partnerID=8YFLogxK
U2 - 10.1016/j.ymgme.2013.08.009
DO - 10.1016/j.ymgme.2013.08.009
M3 - Article
C2 - 24035636
AN - SCOPUS:84885427893
SN - 1096-7192
VL - 110
SP - 352
EP - 361
JO - Biochemical Medicine and Metabolic Biology
JF - Biochemical Medicine and Metabolic Biology
IS - 3
ER -